We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.27%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$49B
AUM Growth
+$3.11B
(+6.8%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
21.37%
Holding
1,104
New
303
Increased
294
Reduced
324
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$282M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$205M |
| 3 |
ConocoPhillips
COP
|
+$203M |
| 4 |
Fortive
FTV
|
+$200M |
| 5 |
Merck
MRK
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$665M |
| 2 |
ExxonMobil
XOM
|
+$332M |
| 3 |
Burlington
BURL
|
+$242M |
| 4 |
National Vision
EYE
|
+$186M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.67% |
| 2 | Healthcare | 17.99% |
| 3 | Financials | 14.03% |
| 4 | Consumer Discretionary | 11.97% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Allstate
ALL
$70.8B
| $30.4M | 0.06% |
264,819
-62,900
| -19% | -$6.93M |
|
327
Mettler-Toledo International
MTD
$28.5B
| $30.1M | 0.06% |
26,042
+6,133
| +31% | +$7.11M |
|
328
Insulet
PODD
$9.65B
| $30M | 0.06% |
115,000
+40,000
| +53% | +$10.7M |
|
329
UDR
UDR
$12.3B
| $29.7M | 0.06% |
677,897
+225,539
| +50% | +$9.33M |
|
330
Weyerhaeuser
WY
$18.3B
| $29.7M | 0.06% |
834,400
+4,900
| +0.6% | +$167K |
|
331
Envista
NVST
$4.46B
| $29.6M | 0.06% |
725,000
+12,144
| +2% | +$463K |
|
332
Ameriprise Financial
AMP
$49.5B
| $29.6M | 0.06% |
127,168
-2,400
| -2% | -$519K |
|
333
CBRE Group
CBRE
$42.7B
| $29.5M | 0.06% |
373,000
+3,800
| +1% | +$269K |
|
334
Dollar Tree
DLTR
$24.9B
| $29.5M | 0.06% |
257,549
-818,633
| -76% | -$88M |
|
335
Eastman Chemical
EMN
$8.4B
| $29.5M | 0.06% |
267,693
+3,193
| +1% | +$347K |
|
|
SIVB
336
DELISTED
SVB Financial Group
SIVB
| $29.4M | 0.06% |
59,638
+3,200
| +6% | +$1.57M |
|
|
PARA
337
DELISTED
Paramount Global Class B
PARA
| $29.3M | 0.06% |
650,050
+454,079
| +232% | +$27.7M |
|
338
Amalgamated Financial
AMAL
$1.5B
| $29.3M | 0.06% |
1,765,507
+83,847
| +5% | +$1.36M |
|
339
Avnet
AVT
$7.94B
| $29.3M | 0.06% |
705,000
+60,000
| +9% | +$2.32M |
|
340
Zebra Technologies
ZBRA
$17.2B
| $29M | 0.06% |
59,811
-8,600
| -13% | -$3.84M |
|
341
Stanley Black & Decker
SWK
$15.3B
| $29M | 0.06% |
145,279
+11,068
| +8% | +$2.01M |
|
|
CCV
342
DELISTED
Churchill Capital Corp V
CCV
| $28.9M | 0.06% |
+2,928,504
| New | +$31.5M |
|
343
Voya Financial
VOYA
$9.2B
| $28.6M | 0.06% |
450,000
-150,000
| -25% | -$9.01M |
|
344
Comstock Resources
CRK
$3.88B
| $28.3M | 0.06% |
5,107,443
+427,870
| +9% | +$2.3M |
|
345
Kraft Heinz
KHC
$29.6B
| $28.2M | 0.06% |
705,932
-13,700
| -2% | -$493K |
|
346
Ardelyx
ARDX
$1.2B
| $28.2M | 0.06% |
4,254,892
-745,108
| -15% | -$5.11M |
|
347
Annexon
ANNX
$918M
| $28.1M | 0.06% |
1,009,830
| – | – |
|
|
PDOT.U
348
DELISTED
Peridot Acquisition Corp. II Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PDOT.U
| $27.8M | 0.06% |
+2,800,000
| New | +$27.8M |
|
349
Boston Properties
BXP
$11B
| $27.8M | 0.06% |
274,726
+80,154
| +41% | +$7.82M |
|
|
BHIL
350
DELISTED
Benson Hill, Inc.
BHIL
| $27.8M | 0.06% |
+78,571
| New | +$28.3M |
|
Similar funds
Adage Capital Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Adage Capital Partners held 1,104 positions worth $49B, up 6.8% from $45.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners's Q1 2021 filing shows 303 new, 294 increased, 324 reduced and 153 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M. The largest sale was Royalty Pharma, an estimated $665M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q1 2021 buy was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M.
- Adage Capital Partners added most to Alexion Pharmaceuticals in Q1 2021, an estimated $205M increase.
- Adage Capital Partners's biggest Q1 2021 reduction was Royalty Pharma, cutting an estimated $665M.
- Adage Capital Partners fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $175M.
- Adage Capital Partners's ten largest holdings make up 21% of its $49B portfolio in Q1 2021.
- Adage Capital Partners opened 303 new positions and closed 153 in Q1 2021.
- Adage Capital Partners's portfolio value rose 6.8% quarter-over-quarter to $49B.
Based on Adage Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.